Literature DB >> 16906539

Linking Antley-Bixler syndrome and congenital adrenal hyperplasia: a novel case of P450 oxidoreductase deficiency.

L Williamson1, W Arlt, C Shackleton, R I Kelley, S R Braddock.   

Abstract

The Antley-Bixler syndrome (ABS) is a multiple congenital malformation syndrome with craniosynostosis, radiohumeral synostosis, femoral bowing, choanal atresia or stenosis, joint contractures, urogenital abnormalities and, often, early death. Autosomal recessive and dominant inheritance have been postulated, as has fluconazole teratogenesis. Mutations in POR (P450 (cytochrome) oxidoreductase, an essential electron donor to enzymes participating in cholesterol biosynthesis), have been identified in some patients with the ABS phenotype. Recent evidence suggests that these mutations cause attenuated steroid hydroxylation, which in turn, causes congenital adrenal hyperplasia (CAH) with ambiguous genitalia in both sexes and glucocorticoid deficiency. Here, we report on a new patient with findings of both ABS and CAH that further illustrates how low maternal estriol at prenatal screening can serve as a marker steroid facilitating early diagnosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16906539     DOI: 10.1002/ajmg.a.31385

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

Review 1.  Craniofacial malformations and their association with brain development: the importance of a multidisciplinary approach for treatment.

Authors:  Asher Ornoy
Journal:  Odontology       Date:  2019-06-06       Impact factor: 2.634

Review 2.  Congenital adrenal hyperplasia, disorders of sex development, and infertility in patients with POR gene pathogenic variants: a systematic review of the literature.

Authors:  C Gusmano; R Cannarella; A Crafa; F Barbagallo; S La Vignera; R A Condorelli; A E Calogero
Journal:  J Endocrinol Invest       Date:  2022-07-17       Impact factor: 5.467

3.  Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.

Authors:  Nils Krone; Nicole Reisch; Jan Idkowiak; Vivek Dhir; Hannah E Ivison; Beverly A Hughes; Ian T Rose; Donna M O'Neil; Raymon Vijzelaar; Matthew J Smith; Fiona MacDonald; Trevor R Cole; Nicolai Adolphs; John S Barton; Edward M Blair; Stephen R Braddock; Felicity Collins; Deborah L Cragun; Mehul T Dattani; Ruth Day; Shelley Dougan; Miriam Feist; Michael E Gottschalk; John W Gregory; Michaela Haim; Rachel Harrison; Ann Haskins Olney; Berthold P Hauffa; Peter C Hindmarsh; Robert J Hopkin; Petr E Jira; Marlies Kempers; Michiel N Kerstens; Mohamed M Khalifa; Birgit Köhler; Dominique Maiter; Shelly Nielsen; Stephen M O'Riordan; Christian L Roth; Kate P Shane; Martin Silink; Nike M M L Stikkelbroeck; Elizabeth Sweeney; Maria Szarras-Czapnik; John R Waterson; Lori Williamson; Michaela F Hartmann; Norman F Taylor; Stefan A Wudy; Ewa M Malunowicz; Cedric H L Shackleton; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2011-12-07       Impact factor: 5.958

4.  Clinical, endocrinological, and molecular features of four Korean cases of cytochrome P450 oxidoreductase deficiency.

Authors:  Yena Lee; Jin-Ho Choi; Arum Oh; Gu-Hwan Kim; Sook-Hyun Park; Jung Eun Moon; Cheol Woo Ko; Chong-Kun Cheon; Han-Wook Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-06-30

Review 5.  46,XX DSD due to Androgen Excess in Monogenic Disorders of Steroidogenesis: Genetic, Biochemical, and Clinical Features.

Authors:  Federico Baronio; Rita Ortolano; Soara Menabò; Alessandra Cassio; Lilia Baldazzi; Valeria Di Natale; Giacomo Tonti; Benedetta Vestrucci; Antonio Balsamo
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

6.  In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.

Authors:  Muhammad Nurhafizuddin; Aziemah Azizi; Long Chiau Ming; Naeem Shafqat
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

Review 7.  Genetic Syndromes Associated with Craniosynostosis.

Authors:  Jung Min Ko
Journal:  J Korean Neurosurg Soc       Date:  2016-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.